Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ DroneShield-Aktie legt zu: Institutionelle Verschiebungen im Blick (Finanzen.net) +++ DRONESHIELD Aktie +6,57%

WUXI BIOLOGICS Aktie

 >WUXI BIOLOGICS Aktienkurs 
3.704 EUR    +4.8%    (Tradegate)
Ask: 3.799 EUR / 922 Stück
Bid: 3.703 EUR / 946 Stück
Tagesumsatz: 2000 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
WUXI BIO Aktie über LYNX handeln
>WUXI BIOLOGICS Performance
1 Woche: -5,6%
1 Monat: +3,2%
3 Monate: -14,4%
6 Monate: +30,4%
1 Jahr: +63,0%
laufendes Jahr: +67,7%
>WUXI BIOLOGICS Aktie
Name:  WUXI BIOLOGICS-0,0000083
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  KYG970081173 / A2QJCN
Symbol/ Ticker:  1FW2 (Frankfurt)
Kürzel:  FRA:1FW2, ETR:1FW2, 1FW2:GR
Index:  -
Webseite:  https://www.wuxibiologics..
Profil:  Wuxi Biologics (Cayman) Inc. is a major player in ..
>Volltext..
Marktkapitalisierung:  14719.65 Mio. EUR
Unternehmenswert:  14324.3 Mio. EUR
Umsatz:  2351.43 Mio. EUR
EBITDA:  846.56 Mio. EUR
Nettogewinn:  491.73 Mio. EUR
Gewinn je Aktie:  0.12 EUR
Schulden:  607.7 Mio. EUR
Liquide Mittel:  1005.82 Mio. EUR
Operativer Cashflow:  691.4 Mio. EUR
Bargeldquote:  1.48
Umsatzwachstum:  5.73%
Gewinnwachstum:  43.75%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  WUXI BIOLOGICS, WUXI BIO
Letzte Datenerhebung:  19.12.25
>WUXI BIO Kennzahlen
Aktien/ Unternehmen:
Aktien: 4128.11 Mio. St.
Frei handelbar: 86.66%
Leerverk. Aktien: -
Rückkaufquote: 1.21%
Mitarbeiter: 12575
Umsatz/Mitarb.: 0.18 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 31.95%
Bewertung:
KGV: 30.72
KGV lG: 26.8
KUV: 6.24
KBV: 2.71
PEG-Ratio: 0.48
EV/EBITDA: 16.92
Rentabilität:
Bruttomarge: 42.65%
Gewinnmarge: 20.91%
Operative Marge: 27.38%
Managementeffizenz:
Gesamtkaprendite: 7.16%
Eigenkaprendite: 9.74%
>WUXI BIO Peer Group

Es sind 101 Aktien bekannt.
 
19.12.25 - 06:00
H Shrs: HSI Rises 165 Pts at Midday; HSBC HOLDINGS Hits New Highs; WUXI BIO Surges 6%+ (AAStocks)
 
The HSI settled the midday up 165 points or 0.65% at 25,663. The HSCEI rose 44 points or 0.5% to 8,885. The HSTECH climbed 61 points or 1.1% to 5,480. The market's midday turnover amounted to HKD97.521 billion.TikTok and Oracle (ORCL.US) formed a US joint venture, with ByteDance retaining US e-commerce and advertising operat......
19.12.25 - 05:15
Midday Takeaway: HSI Closes Midday at 25,663, Up 165 pts; HSTI Closes Midday at 5,480, Up 61 pts; WUXI BIO Up over 6%; HSBC HOLDINGS, TANWAN, NCI, HYSAN DEV Hit New Highs (AAStocks)
 
At midday close, HSI rose 165 pts or 0.6% to 25,663. HSTI rose 61 pts or 1.1% to 5,480. HSCEI gained 44 pts or 0.5% to 8,885.Active Heavyweights:MEITUAN (03690.HK) closed at $103.7, up 2.3%TENCENT (00700.HK) closed at $612, up 1.2%BABA (09988.HK) closed at $145.2, up 0.8%PING AN (02318.HK) closed at $65.35, up 0.2%XIAOMI (01810.......
02.12.25 - 09:48
WuXi Biologics Extends Global CRDMO Network to Qatar Through Strategic MoU Signed with Qatar Free Zones Authority (PR Newswire)
 
DOHA, Qatar, Dec. 2, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has signed a strategic Memorandum of Understanding (MoU) with the Qatar Free Zones Authority (QFZ) to extend......
02.12.25 - 08:15
WUXI BIO Forms Strategic Partnership with Qatar Free Zones Authority (AAStocks)
 
WUXI BIO (02269.HK) has entered into a strategic Memorandum of Understanding (MOU) with the Qatar Free Zones Authority (QFZ) to extend its global network and capabilities to the Middle East, as announced by WUXI BIO.The Company looks forward to contributing to this growing ecosystem while enabling its clients to deliver high-qua......
22.10.25 - 02:33
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index (PR Newswire)
 
The only company from pharmaceutical industry selected for inclusion in the Index Also included in HSI ESG Index and Hang Seng ESG 50 Index Green CRDMO solution provider with outstanding sustainability performance HONG KONG, Oct. 21, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a......
20.10.25 - 11:33
WuXi Biologics Honored with 2025 Global Customer Value Leadership Recognition by Frost & Sullivan (PR Newswire)
 
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has been honored with the Frost & Sullivan's 2025 Global Customer Value Leadership Recognition in the......
10.10.25 - 02:33
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year (PR Newswire)
 
SHANGHAI, Oct. 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced it has received the esteemed AAA ESG rating from Morgan Stanley Capital International (MSCI) for the third consecutive year.......
30.09.25 - 10:15
Full-day Takeaway: HSI Closes at 26,855, Up 232 pts; HSTI Closes at 6,465, Up 141 pts; WUXI APPTEC Up over 8%; KUAISHOU-W, SMIC, WUXI BIO, ZIJIN MINING, HSBC HOLDINGS Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 232 pts or 0.9% to 26,855. HSTI rose 141 pts or 2.2% to 6,465. HSCEI gained 101 pts or 1.1% to 9,555. Market turnover reached $314.93 billion.Active Heavyweights:BABA (09988.HK) closed at $177, up 2.1%MEITUAN (03690.HK) closed at $104.5, up 1.7%XIAOMI (01810.HK) closed at $54, up 0.8%TENCENT (00700.HK) closed ......
26.09.25 - 04:00
WUXI BIO Tumbles 3%+ as US to Levy 100% Tariff on Branded & Patented Drugs (AAStocks)
 
From October 1 onwards, the US will impose a 100% tariff on branded or patented drugs except on those from companies with established or under-construction pharmaceutical facilities in the US.Dragged down by the news, WUXI BIO (02269.HK) opened down 2.95% today (26th) and once bottomed at HKD38.42. It last traded at HKD38.54, do......
25.09.25 - 13:45
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™,to Accelerate Biologics Development with High Titer and Superior Stability (PR Newswire)
 
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability. The platform has achieved an average mAb titer exceeding 8.0 g/L with over 99% of clonal cell lines maintaining......
23.09.25 - 06:01
WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year (PR Newswire)
 
SHANGHAI, Sept. 23, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been selected as a constituent company of the FTSE4Good Index Series, marking the fifth consecutive year the......
22.09.25 - 10:15
Full-day Takeaway: HSI Closes at 26,344, Down 200 pts; HSTI Closes at 6,257, Down 36 pts; SUNNY OPTICAL Up over 6%; WUXI BIO, SMIC, FIT HON TENG, COWELL, WUXI XDC Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI dropped 200 pts or 0.8% to 26,344. HSTI dropped 36 pts or 0.6% to 6,257. HSCEI fell 101 pts or 1.1% to 9,370. Market turnover reached $290.54 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $103.9, down 2.3%PING AN (02318.HK) closed at $52.95, down 1.9%XIAOMI (01810.HK) closed at $56.1, down 1.1%TENCENT (0......
19.09.25 - 10:54
Chinese biotechs get a shot in the arm from policy support, licensing deals (SCMP)
 
Chinese biopharmaceutical stocks have become extremely popular with investors this year amid strong policy support and a rise in licensing deals with multinational companies. A more than 100 per cent gain in the Hang Seng innovative drug index this year is an indication of the euphoria sweeping the sector. Key industry players such as Hansoh Pharmaceutical Group and WuXi Biologics, which are also members of the Hang Seng Index, have more than doubled year to date. The trade is reminiscent of the......
17.09.25 - 06:03
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK) (PR Newswire)
 
WUXI, China, Sept. 17, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturing facilities in Wuxi – MFG1, MFG2, and DP5 – have received GMP certification from Türkiye......
15.09.25 - 10:15
Full-day Takeaway: HSI Closes at 26,446, Up 58 pts; HSTI Closes at 6,043, Up 54 pts; WUXI BIO Up over 6%; BABA, NONGFU SPRING, NTES, TRANSTHERA-B, BAYZED HEALTH Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 58 pts or 0.2% to 26,446. HSTI rose 54 pts or 0.9% to 6,043. HSCEI gained 19 pts or 0.2% to 9,384. Market turnover reached $290.19 billion.Active Heavyweights:BABA (09988.HK) closed at $154.6, up 2.3%, hitting new highXIAOMI (01810.HK) closed at $56.2, up 1.9%MEITUAN (03690.HK) closed at $97.35, up 0.8%TENCENT......
12.09.25 - 03:33
WuXi Biologics Achieves "CDMO of the Year" Among Three Prestigious IMAPAC Awards (PR Newswire)
 
SINGAPORE, Sept. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has received the "CDMO of the Year – Asia Pacific", "Best Biologics CDMO Award: Bioprocessing", and "Best......
09.09.25 - 12:03
WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry (PR Newswire)
 
End-to-end Green CRDMO solutions to enable global clients for broader positive impact Span from biologics research, development, manufacturing, and overall operations Integration with lean management and digitalization for continuous excellence A comprehensive ecosystem featuring diverse......
08.09.25 - 10:15
Full-day Takeaway: HSI Closes at 25,633, Up 215 pts; HSTI Closes at 5,753, Up 66 pts; BABA Up over 4%; WUXI BIO, BOC HONG KONG, SINO BIOPHARM, CHOW TAI FOOK, SKYWORTH Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 215 pts or 0.8% to 25,633. HSTI rose 66 pts or 1.2% to 5,753. HSCEI gained 64 pts or 0.7% to 9,121. Market turnover reached $286.04 billion.Active Heavyweights:BABA (09988.HK) closed at $137.3, up 4.2%XIAOMI (01810.HK) closed at $54.75, up 2.1%TENCENT (00700.HK) closed at $617.5, up 2%PING AN (02318.HK) closed......
08.09.25 - 06:15
Midday Takeaway: HSI Closes Midday at 25,508, Up 90 pts; HSTI Closes Midday at 5,702, Up 15 pts; BABA Up over 3%; WUXI BIO, CHOW TAI FOOK, FOSUN PHARMA, HORIZONROBOT-W, CHINA LESSO Hit New Highs (AAStocks)
 
At midday close, HSI rose 90 pts or 0.4% to 25,508. HSTI rose 15 pts or 0.3% to 5,702. HSCEI gained 15 pts or 0.2% to 9,072.Active Heavyweights:BABA (09988.HK) closed at $136.7, up 3.7%XIAOMI (01810.HK) closed at $54.3, up 1.2%TENCENT (00700.HK) closed at $612, up 1.1%MEITUAN (03690.HK) closed at $102.5, down 0.5%HSI & HSCEI Con......
01.09.25 - 10:15
Full-day Takeaway: HSI Up 539 pts; HSTI Up 124 pts; BABA Up over 18%; WUXI BIO, ZIJIN MINING, SINO BIOPHARM, SMIC, WH GROUP Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 539 pts or 2.2% to 25,617. HSTI rose 124 pts or 2.2% to 5,798. HSCEI gained 174 pts or 1.9% to 9,121. Market turnover reached $380.23 billion.Active Heavyweights:BABA (09988.HK) closed at $137.1, up 18.5%XIAOMI (01810.HK) closed at $54, up 2.2%TENCENT (00700.HK) closed at $605, up 1.4%PING AN (02318.HK) closed......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Eine schüchterne Katze macht eine stolze Maus. - Sprichwort Großbritannien
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!